After a brief introduction (I.) and a closer look at the exact timeline (II.) of the Artificial Intelligence Act, the article addresses key questions ranging from regulated AI applications over the risk-based approach and the classification system to the wide range of high-risk AI systems (III.) before a conclusion concerning the likely impact of the AI Act is drawn (IV.).
No takes yet. Share an insight, caveat, or question.
Keber et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: